Alan Clucas, BM, BCh, MA, FRCP(UK), FFPM
Alan Clucas was the Head of Clinical Sciences in the Pfizer Global Innovative Pharmaceuticals Medicines Development Group. He authored the articles Clinical Trial Practices – Safeguards in ResearchClinical Trial Practices – Safeguards in Research and Joining a Clinical Trial: What to Know Before You EnrollJoining a Clinical Trial: What to Know Before You Enrol during his employment at Pfizer.
Dr. Clucas holds an MA in physiology and a medical degree from Oxford University. He originally trained in internal medicine in the UK and is a Fellow of the Royal College of Physicians of London. During his 30-year career in the pharmaceutical industry, Dr. Clucas has gained experience in a broad range of therapeutic areas including allergy/immunology, cardiovascular/metabolic diseases, dermatology, gastroenterology, inflammation/pain and neurosciences, in both early and late phase clinical trials. Dr. Clucas has extensive experience in designing and implementing organizational change, and in leading or sponsoring continuous improvement and quality initiatives.